NEOPLASMA
Article List
Volume 63, 2016, No. 5
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Content:
- KUSENDA, J. - KOVARIKOVA, A.: Multiple myeloma, immunotherapy and minimal residual disease. (p. 651)
- KOSIK, P. - SKORVAGA, M. - BELYAEV, I.: Incidence of preleukemic fusion genes in healthy subjects. (p. 659)
- JIANG, Z. - WANG, H. - LI, Y. - HOU, Z. - MA, N. - CHEN, W. - ZONG, Z. - Chen, S.: MiR-129-5p is down-regulated and involved in migration and invasion of gastric cancer cells by targeting interleukin-8. (p. 673)
- JO, Y. - OH, H. - KIM, M. - YOO, N. - LEE, S.: Frameshift mutations of OGDH, PPAT and PCCA genes in gastric and colorectal cancers. (p. 681)
- NOVOTNA, B. - TAKACOVA, M. - HUDECOVA, S. - LENCESOVA, L. - BREZA, J. - MISAK, A. - CSADEROVA, L. - PASTOREKOVÁ, S. - KRIZANOVA, O.: Activation of the ER stress and calcium signaling in angiomyolipoma. (p. 687)
- LIANG, T. - Guo, Q. - LI, L. - CHENG, Y. - REN, C. - ZHANG, G.: MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1. (p. 696)
- MAO, D. - QIAO, L. - LU, H. - FENG, Y.: B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway. (p. 705)
- WANG, X. - LI, H. - Cui, L. - FENG, J. - FAN, Q.: MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R. (p. 717)
- XU, G. - Niu, Z. - Dong, J. - ZHAO, Y. - ZHANG, Y. - LI, X.: Noscapine inhibits human hepatocellular carcinoma growth through inducing apoptosis in vitro and in vivo. (p. 726)
- LI, C. - GUO, D. - TANG, B. - ZHANG, Y. - ZHANG, K. - NIE, L.: Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression. (p. 734)
- VALKOVA, V. - JIRCIKOVA, J. - TRNKOVA, M. - STEINEROVA, K. - KESLOVA, P. - LANSKA, M. - KORISTEK, Z. - RAIDA, L. - KREJCI, M. - KRUNTORADOVA, K. - DOLEZAL, T. - BENEŠOVÁ, K. - CETKOVSKÝ, P. - TRNENY, M.: The quality of life following allogeneic hematopoietic stem cell transplantation – a multicenter retrospective study. (p. 743)
- PLESKO, M. - SUVADA, J. - MAKOHUSOVA, M. - WACZULIKOVA, I. - BEHULOVA, D. - VASILENKOVA, A. - VARGOVA, M. - STECOVA, A. - KAISEROVA, E. - KOLENOVA, A.: The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients. (p. 752)
- BAN, M. - VICULIN, J. - TOMIC, S. - CAPKUN, V. - STRIKIC, A. - MISE, B. - UTROBICIC, I. - VRDOLJAK, E.: Retrospective analysis of efficacy of trastuzumab in adjuvant treatment of HER 2 positive early breast cancer – single institution experience. (p. 761)
- ZAWLIK, I. - GABLO, N. - SZYMANSKA, B. - PAWLOWSKA, Z. - CHUDOBINSKI, C. - CHALUBINSKA-FENDLER, J. - MORAWIEC, Z. - ZIELINSKA-BLIZNIEWSKA, H. - MORAWIEC-SZTANDERA, A. - KOLACINSKA, A.: Immune checkpoints in aggressive breast cancer subtypes. (p. 768)
- KLANOVA, M. - SOUKUP, T. - MOLINSKY, J. - LATECKOVA, L. - VOCKOVA, P. - ALAM, M. - ZIVNY, J. - TRNENY, M. - KLENER, P.: Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model. (p. 774)
- WAYHELOVA, M. - Mikulasova, A. - Smetana, J. - VALLOVA, V. - BLAZKOVA, D. - FILKOVA, H. - MOUKOVA, L. - KUGLIK, P.: Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM). (p. 779)
- WANG, Y. - SUN, J. - Zheng, R. - SHAO, Q. - GAO, W. - SONG, B. - CHEN, X. - QU, X.: Regulatory T cells are an important prognostic factor in breast cancer: a systematic review and meta-analysis. (p. 789)
- POSPISILOVA, S. - PAZOURKOVA, E. - HORINEK, A. - BRISUDA, A. - SVOBODOVA, I. - SOUKUP, V. - HRBACEK, J. - CAPOUN, O. - HANUS, T. - MARES, J. - KORABECNA, M. - BABJUK, M.: MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection. (p. 799)
- WU, B. - SHI, N. - SUN, L. - LIU, L.: Clinical value of high expression level of CD71 in acute myeloid leukemia. (p. 809)
- SHANDIZ, F. - KADKHODAYAN, S. - GHAFFARZADEGAN, K. - ESMAEILY, H. - TORABI, S. - KHALES, S.: The impact of p16 and HER2 expression on survival in patients with ovarian carcinoma. (p. 816)